Which Weight Management Injection Works Best for You?
Is Wegovy Better Than Mounjaro for UK Patients in 2026?
The question of whether Wegovy is better than Mounjaro depends entirely on your individual medical profile, lifestyle needs, and clinical response. Wegovy (semaglutide) is a GLP-1 receptor agonist that has been available in the UK since 2022, whilst Mounjaro (tirzepatide) represents a newer dual-action approach targeting both GIP and GLP-1 receptors. Both are prescription-only medicines that require clinical assessment and ongoing medical supervision. At EverydayMeds, we maintain comprehensive stock levels of both medications, ensuring UK patients can access their prescribed treatment without the supply interruptions that have historically affected weight management injections.
The availability advantage cannot be overstated for patients wondering if Wegovy is better than Mounjaro in practical terms. Our GPhC-registered pharmacy (#9012878) has established reliable supply chains with both Novo Nordisk (Wegovy) and Eli Lilly (Mounjaro), meaning you can start your prescribed treatment immediately rather than joining waitlists. This consistent availability allows prescribers to choose the most clinically appropriate option for each patient, rather than being limited by stock shortages. Both medications follow structured dose escalation protocols, and having assured access to each dose strength ensures your treatment journey remains uninterrupted.
Wegovy vs Mounjaro Pricing: Transparent UK Costs
When evaluating whether Wegovy is better than Mounjaro from a cost perspective, transparency in pricing becomes crucial for UK patients. Wegovy at EverydayMeds starts at £79.99 for the 0.25mg starter dose (using code FIRST40), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our bundle options provide convenience for patients wanting to secure multiple doses, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Ultimate Stability Trio (three 2.4mg pens) for £649.99. Returning customers benefit from code DOSE25 applied at checkout.
Mounjaro pricing follows a different structure reflecting its newer market position, but both medications represent significant investments in long-term weight management. The question of whether Wegovy is better than Mounjaro financially often comes down to insurance coverage, individual response rates, and treatment duration. EverydayMeds provides clear, upfront pricing without hidden fees, including our cold-chain delivery service that maintains medication efficacy from our pharmacy to your door. This transparency allows patients and prescribers to make informed decisions based on both clinical suitability and budget considerations.
Clinical Evidence: Is Wegovy Better Than Mounjaro in Trials?
Determining if Wegovy is better than Mounjaro requires careful examination of their respective clinical trial programmes, though direct head-to-head comparisons remain limited. Wegovy's efficacy was demonstrated in the landmark STEP trials, with STEP 1 showing approximately 15% average weight loss at 68 weeks when used alongside diet and exercise interventions (Wilding et al., NEJM, 2021). The STEP programme also revealed sustained weight loss at 2 years (STEP 5) and cardiovascular benefits in the SELECT trial, with a 20% reduction in major cardiovascular events.
Mounjaro's SURMOUNT trials demonstrated the potential advantages of dual GIP/GLP-1 receptor activation, though comparing these results directly to Wegovy's STEP data would be inappropriate due to different trial designs, patient populations, and endpoints. Both medications have shown clinically meaningful weight loss in their respective studies when used as prescription-only medicines alongside lifestyle interventions. The question of whether Wegovy is better than Mounjaro ultimately depends on individual patient factors that only qualified prescribers can assess through proper clinical evaluation.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Understanding whether Wegovy is better than Mounjaro starts with comprehending how semaglutide functions as a GLP-1 receptor agonist. Wegovy mimics the action of glucagon-like peptide-1, a naturally occurring hormone that regulates blood sugar and appetite control. When administered as a once-weekly injection, semaglutide binds to GLP-1 receptors in the brain's appetite centres, promoting feelings of fullness and reducing food cravings. This mechanism helps patients feel satisfied with smaller portions and may reduce the psychological drive to overeat. The medication works most effectively when combined with a reduced-calorie diet and increased physical activity, as these lifestyle changes complement the physiological effects of GLP-1 receptor activation.
Ordering Process: Getting Your Prescribed Wegovy or Mounjaro
Whether you decide Wegovy is better than Mounjaro for your situation, EverydayMeds streamlines access to both medications through our comprehensive online service. The process begins with a 3-minute clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), determining clinical suitability and appropriate dosing. Once approved, your medication ships via next-day delivery using temperature-controlled packaging that maintains the cold-chain integrity essential for injectable medications. This efficient system means you can access your prescribed treatment quickly, regardless of whether your clinician determines Wegovy or Mounjaro is more appropriate for your circumstances.
Storage and Practical Considerations: Wegovy vs Mounjaro Convenience
When determining if Wegovy is better than Mounjaro for your lifestyle, storage requirements present a clear practical difference. Wegovy can be stored at room temperature for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day limit. This storage advantage makes Wegovy more convenient for travel, business trips, or situations where refrigeration access is limited. Both medications require refrigeration at 2-8°C before first use and utilise pre-filled pen devices for once-weekly injection. The FlexTouch pen system used by Wegovy has been refined over years of diabetes treatment experience, whilst Mounjaro employs Eli Lilly's established pen technology. Both medications follow mandatory dose escalation protocols that cannot be skipped, requiring consistent access to increasing dose strengths over the first 16 weeks of treatment.
UK Stock Availability: Why EverydayMeds Ensures Consistent Supply
The historical question of whether Wegovy is better than Mounjaro has often been overshadowed by availability issues, with supply shortages affecting patient access across the UK. EverydayMeds has invested significantly in supply chain relationships with both manufacturers, maintaining stock levels that allow patients to continue their prescribed treatment without interruption. Our inventory management system tracks dose progression for individual patients, ensuring the next strength is available when needed for dose escalation.
This reliable supply becomes crucial when considering that both medications require long-term commitment for sustained results. Clinical trials show that patients who discontinue treatment typically regain approximately two-thirds of their lost weight within one year. By ensuring consistent availability of both Wegovy and Mounjaro, EverydayMeds eliminates supply-related treatment interruptions that could compromise long-term success. Whether your prescriber determines Wegovy is better than Mounjaro for your specific needs, you can be confident that your medication will be available when needed.
Make Your Decision: Expert Support for Wegovy and Mounjaro
Rather than definitively answering whether Wegovy is better than Mounjaro, EverydayMeds provides the clinical assessment and ongoing support necessary for informed decision-making. Our qualified prescribers evaluate factors including your medical history, current medications, lifestyle requirements, and treatment goals to recommend the most appropriate option. Both medications are available from our GPhC-registered pharmacy (#9012878) with transparent pricing and reliable delivery. New customers can use code FIRST40 at checkout, whilst returning customers benefit from code DOSE25. Start your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy to determine which prescription-only medicine offers the best approach for your weight management journey. Our clinical team ensures you receive expert guidance whether Wegovy or Mounjaro proves more suitable for your individual circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
